Tanz Centre for Research in Neurodegenerative Diseases


Researchers Delay Onset of ALS in Laboratory Models

A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis in mice. They are cautiously optimistic that the result, combined with other clinical advances, points to a potential treatment for ALS in humans.
Apr 23 / 2020

Professor Graham Collingridge receives CBE for services to Biomedical Sciences

His Royal Highness Prince Charles honoured Tanz Centre Director Graham Collingridge for his services to Biomedical Sciences, presenting him with a CBE at Buckingham Palace on Feb. 14, 2020. The CBE, or Commander of the Most Excellent Order of the British Empire, is one of five classes of civil awards established in 1917 by King George V.
Feb 27 / 2020

On the Road to Developing New Drugs to Treat Neurodegenerative Disorders

A new study involving a University of Toronto researcher illuminates how drugs could be developed to treat neurodevelopmental, psychiatric and neurodegenerative disorders, by targeting a specific receptor in the brain.
Feb 24 / 2020

Study Finds Genes Aren’t Only Factor Dictating Alzheimer’s Risk

The colour of our eyes or the straightness of our hair is linked to our DNA, but the development of Alzheimer’s disease isn’t exclusively linked to genetics, suggest recently published findings. In the first study published about Alzheimer’s disease among identical triplets, University of Toronto researchers found that despite sharing the same DNA, two of the triplets developed Alzheimer’s while one did not, according to recently published results in the journal Brain. The two triplets that developed Alzheimer’s were diagnosed in their mid-70s.
Jan 7 / 2020